New IMS data reveals the growing importance of generic medicines for public health as they now account for 62% of medicines dispensed in Europe delivering huge value while impacting only 4% of total healthcare budgets. 

At the same time a new Economist Intelligence Unit report underlined that unsustainable pricing policies are leading to shortages of essential life-saving medicines. Global industry leaders and regulators advanced a clear proposal to increase regulatory cooperation to ensure safety, quality and efficacy while reducing administrative redundancies.